跳到主要內容區塊
考生 在校生 教職員 校友 訪客
單位自訂圖片
返回
文字大小: 小 中 大
:::
:::

湯松陵 副教授

🧪 藥物科學領域
Teacher Photo
湯松陵 副教授
Sung-Ling Tang
📞 聯絡資訊
辦公室房間號碼：9311室
電話：02-8792-3100 分機 18856
電子郵件：tangling@mail.ndmctsgh.edu.tw
🏛 現職
國防醫學大學藥學系副教授
🎓 學歷
2012.09～2019.06 臺灣科技大學應用科技研究所博士
2009.11～2010.04 美國華盛頓大學藥學院藥學系短期進修
2001.08～2003.07 國防醫學院藥學研究所碩士
1996.08～2000.07 國防醫學院藥學系學士
🏛 經歷
2026.02～迄今 國防醫學大學藥學系副教授
2024.01～2026.02 國防醫學院藥學系助理教授
2022.07.16～2023.12.31 三軍總醫院臨床藥學部臨藥科主任
2021.11.16～2022.07.15 國防部軍醫局藥政管理處視察
2019.08～2026.01 國防醫學院藥學系助理教授
2018.04.01～2021.11.15 三軍總醫院臨床藥學部調劑科主任
2017.03.16～2018.03.31 國防部軍醫局藥政管理處編審
2013.08～2018.03 三軍總醫院臨床藥學部資深藥師
2012.08～2013.07 三軍總醫院臨床藥學部總藥師
2010.05～2012.07 三軍總醫院臨床藥學部調製組組長／藥物品管室藥師
2005.07～2010.04 三軍總醫院臨床藥學部藥師
🔬 專長
藥劑學、藥物遞送、奈米製劑、臨床藥學與治療學
🧾 論文著作
※ 可上下捲動瀏覽 
  1. W.-A. LIN, S.-L. TANG, Y.-H. TARN. Cost-utility analysis of different peg-interferon alpha-2b plus ribavirin treatment strategies as initial therapy for naïve Chinese patients with chronic hepatitis C. Alimentary Pharmacology and Therapeutics. 2006, 24(10), 1483–1493.
  2. Hu, Chieh-Shen, Tang, Sung-Ling, Chiang, Chiao-His, Hosseinkhani, Hossein, Hong, Po-Da. Characterization and anti-tumor effects of chondroitin sulfate–chitosan nanoparticles delivery system. Journal of Nanoparticle Research. 2014, 16(11):2672.
  3. Tang, Sung-Ling, Bai, Meng-Yi, Wang, Jyun-Yi, Hong, Po-Da. Development and application of micro-polysaccharide drug carriers incorporating doxorubicin and superparamagnetic iron oxide for bimodality treatment of hepatocellular carcinoma. Colloids and Surfaces B: Biointerfaces. 2017, 151:304-313.
  4. Meng-Yi Bai, Sung-Ling Tang, Meng-Han Chuang, Ting-Ying Wang, Po-da Hong. Evaluation of chitosan derivative microparticles encapsulating superparamagnetic iron oxide and doxorubicin as a pH-sensitive delivery carrier in hepatic carcinoma treatment: an in vitro comparison study. Frontiers in Pharmacology. 2018 Sep 21;9:1025.
  5. Meng-Yi Bai, Meng-Han Chuang, Ming-Fang Lin, Sung-Ling Tang, Chin-Chean Wong, Wing P. Chan. Relationships of age and sex with cytokine content and distribution in human platelet fibrin gels. Scientific Reports. 2018 Jul 13;8:10642.
  6. Yu-Chi Wang, Meng-Yi Bai, Ying-Ting Yeh, Sung-Ling Tang, Mu-Hsien Yu. CD133 targeted PVP/PMMA microparticle incorporating levamisole for the treatment of ovarian cancer. Polymers. 2020 Feb 20;12(2):479.
  7. Bashir Lawal, Yu-Cheng Kuo, Sung-Ling Tang, Feng-Cheng Liu, Alexander T.H. Wu, Hung-Yun Lin, Hsu-Shan Huang. Transcriptomic-based identification of the immuno-oncogenic signature of cholangiocarcinoma for HLC-018 multi-target therapy exploration. Cells. 2021 Oct 25;10(11):2873.
  8. Ntlotlang Mokgautsi, Yu-Cheng Kuo, Sung-Ling Tang, Feng-Cheng Liu, Shiang-Jiun Chen, Alexander T.H. Wu, Hsu-Shan Huang. Anticancer activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c]quinolin-11-one (SJ10) in glioblastoma multiforme (GBM) chemoradioresistant cell cycle-related oncogenic signatures. Cancers. 2022 Jan 5;14(1):262.
  9. Meng-Yi Bai, Vu Pham Thao Vy, Sung-Ling Tang, Truong Nguyen Khanh Hung, Ching-Wei Wang, Jui-Yuan Liang, Chin-Chean Wong, Wing P. Chan. Current progress of platelet-rich derivatives in cartilage and joint repairs. International Journal of Molecular Sciences. 2023 Aug 9;24(16):12608.
  10. Sung-Ling Tang, Kai-Yi Wang, Wen-Kai Hsiao, Chi-Kang Lin. Breast milk excretion of dinalbuphine sebacate injection administered after cesarean section. Journal of Clinical Pharmacology. 2024 Mar 1;64(6):755–761.
  11. Meng-Yi Bai, Yu-Ting Liu, Ying-Ting Yeh, Yi-Ling Hong, Yi-Ju Tsai, Yu-Chi Wang, Masahi Kurashina, Mikito Yasuzawa, Sung-Ling Tang. Development and application of a crosslinked gelatin foam dressing for wound recovery. Natural Sciences. 2025 Mar 19;5:e70001.
  12. Sung-Ling Tang, Maryam Rachmawati Sumitra, Yu-Cheng Kuo, Han-Lin Hsu, Muhamad Ansar, Sheng-Liang Huang, Shih-Yu Lee, Hong-Jaan Wang, Bashir Lawal, Alexander T.H. Wu, Lung-Ching Chen, Hsu-Shan Huang. Computer-aided drug discovery of a dual-target inhibitor for ovarian cancer: therapeutic intervention targeting CDK1/TTK signaling pathway and structural insights in the NCI-60. Comput Biol Med. 2025 Jul;193:110445.
  13. Ren-Jong Liang, Shu-Hao Hsu, Hsueh-Tien Chen, Wan-Han Chen, Han-Yu Fu, Hsin-Ying Chen, Hong-Jaan Wang, Sung-Ling Tang. Selection of an optimal metabolic model for accurately predicting the hepatic clearance of albumin-binding-sensitive drugs. Pharmaceuticals. 2025 Jul 1.
  14. Hsin-Chung Cheng, Hsueh-Tien Chen, Hsin-Ying Chen, Nai-Hsin Chou, Hong-Jaan Wang, Li-Heng Pao, Sung-Ling Tang. Advancing hepatic clearance prediction across in vitro, ex situ, and in vivo systems to facilitate in vitro-to-in vivo extrapolation. European Journal of Pharmaceutical Sciences. 2025 Jun 15;212:107171.
  • 瀏覽人次:1057
  • 更新日期:2026-08-19